FDA Drugs (New Approvals & NDA)Original article
DuPont Nutrition USA Inc. - 627211 - 07/22/2026
RegulatoryNegative
AI Analysis
Summary
DuPont Nutrition USA Inc. received a regulatory action from FDA on July 22, 2026 related to CGMP violations and adulterated drug products.
Outcome Details
CGMP/Drug Products/Adulterated - Regulatory action related to current Good Manufacturing Practice violations and adulterated drug products
Importance:6/10
Sentiment:
-0.80
regulatory_actionCGMP_violationdrug_adulterationmanufacturingcompliance
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 30, 2026 6:20 PM